Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
18
# OF OVERLAPPING
HOLDINGS
WDNA
80
HOLDINGS
24%
ALSO IN CANC
CANC
52
HOLDINGS
35%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 3.8% | 4.2% | 3.8% |
|
IMMUNOME, INC. | 2.8% | 4.1% | 2.8% |
|
JOHNSON & JOHNSON | 3.1% | 2.5% | 2.5% |
 |
ASTRAZENECA PLC | 2.1% | 3.5% | 2.1% |
|
AMGEN INC | 1.6% | 2.1% | 1.6% |
WDNA Overweight Relative to CANC
|
TWIST BIOSCIENCE CORP. | 4.1% |
|
MODERNA, INC. | 3.1% |
|
UNITED THERAPEUTICS CORP | 3.0% |
|
DARLING INTERNATIONAL INC | 2.6% |
|
TEMPUS AI INC | 2.5% |
|
STOKE THERAPEUTICS, INC. | 2.5% |
|
CORTEVA INC | 2.2% |
|
BEAM THERAPEUTICS, INC. | 2.2% |
 |
BUNGE GLOBAL SA | 2.1% |
|
IONIS PHARMACEUTICALS, INC. | 2.1% |
WDNA Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.6% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.2% |
|
COGENT BIOSCIENCES INC | -4.1% |
|
CELCUITY INC. | -3.6% |
|
BRISTOL-MYERS SQUIBB CO | -3.3% |
|
NUVALENT, INC. CLASS A | -3.3% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.2% |
|
MERCK & CO. INC. | -2.7% |
|
ABBVIE INC | -2.6% |
|
NOVARTIS AG | -2.6% |